Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs
Sign Up to like & getrecommendations! Published in 2020 at "Theranostics"
DOI: 10.7150/thno.46794
Abstract: Aplastic anemia (AA) is characterized as hypoplasia of bone marrow hematopoietic cells and hematopenia of peripheral blood cells. Though the supplement of exogenous erythropoietin (EPO) has been clinically approved for AA treatment, the side-effects hinder… read more here.
Keywords: aplastic anemia; treatment; erythrocyte; robust treatment ... See more keywords